Investigating how radiation therapy can improve treatment for limited metastatic prostate cancer.
Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center
This study is looking at how radiation therapy can help men with prostate cancer that has spread to a few places in the body, aiming to see if it can stop the cancer from getting worse and improve treatment options for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10910075 on NIH RePORTER |
What this research studies
This research focuses on understanding the complex process of metastasis in prostate cancer, particularly in cases where the cancer has spread but remains limited in number and location, known as oligometastasis. The study aims to explore how radiation therapy can be used to consolidate tumor deposits and potentially prevent further progression of the disease. By collaborating with experts from multiple prestigious institutions, the research employs advanced clinical trials and computational methods to analyze the effects of radiation on metastatic cancer. Patients may benefit from new treatment strategies that could enhance their management and outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with oligometastatic prostate cancer who have limited metastases.
Not a fit: Patients with advanced metastatic prostate cancer that is not oligometastatic may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for patients with oligometastatic prostate cancer, potentially increasing survival rates and quality of life.
How similar studies have performed: Previous studies have shown promising results in using radiation therapy for oligometastatic prostate cancer, indicating that this approach may be effective.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Tran, Phuoc T. — University of Maryland Baltimore
- Study coordinator: Tran, Phuoc T.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.